Stocks and Investing
Stocks and Investing
Fri, August 2, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Amsellem Downgraded (BHC) to Sell and Decreased Target to $3 on, Aug 2nd, 2024
David Amsellem of Piper Sandler, Downgraded "Bausch Health Companies Inc." (BHC) to Sell and Decreased Target from $9 to $3 on, Aug 2nd, 2024.
David has made no other calls on BHC in the last 4 months.
There are 2 other peers that have a rating on BHC. Out of the 2 peers that are also analyzing BHC, all agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Gregory Fraser of "Truist Securities" Maintained at Hold with Decreased Target to $7 on, Thursday, July 25th, 2024
- Michael Freeman of "Raymond James" Initiated at Hold and Held Target at $8 on, Wednesday, July 10th, 2024
Contributing Sources